IBM falls most in 15 months on tepid software sales
Second-quarter software unit sales increased 10 per cent to US$7.39 billion, the company said in a statement on Wednesday, slightly below analysts' average estimate of US$7.49 billion. The company's consulting business, which has been experiencing a growth slump, generated a revenue bump of 3 per cent to US$5.31 billion.
Investors have been enthusiastic about IBM's software business and the potential for future growth from artificial intelligence tools and quantum computing.
The company's management has heralded software and services as the path to rejuvenation since the 1990s. However, only recently under chief executive officer Arvind Krishna has the approach really begun to materialise, with software now more than 40 per cent of the company's annual revenue.
Bookings for the AI business have exceeded US$7.5 billion since mid-2023, the Armonk, New York-based company said. That is up from the US$6 billion IBM disclosed during its last quarterly earnings report in April.
About 80 per cent of the bookings come from the consulting unit, with the rest from software.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
The shares dropped 7.6 per cent to US$260.51 at the close on Thursday in New York. The stock has gained 19 per cent this year, outpacing many technology peers.
Overall, revenue increased 8 per cent to US$17 billion in the period ended June 30, the company said Wednesday in a statement. Analysts, on average, estimated US$16.6 billion.
Much of that performance was due to Big Blue's infrastructure unit. Sales in that division gained 14 per cent to US$4.14 billion, beating the US$3.66 billion anticipated by Wall Street.
This is the strongest initial launch of a mainframe product in IBM's history, chief financial officer Jim Kavanaugh said in an interview. Demand is driven by large enterprises, particularly in the finance and retail industries, he said.
Despite the top line strength, investors are likely to question how durable IBM's software growth is in the second half of the year, wrote Amit Daryanani, an analyst at Evercore ISI.
On a call with analysts after the results were released, Kavanaugh said that Red Hat software sales should continue growing in the mid-teens. The group, which was acquired in 2019, posted 16 per cent growth in the second quarter.
Profit, excluding some items, was US$2.80 per share, compared with the average estimate of US$2.62. Kavanaugh said IBM is targeting steeper cost reductions, which is helping improve margins.
Technology vendors who sell to the US government have been anxious about the impact of cost cuts under the Trump administration. Kavanaugh said that some of IBM's federal contracts that were previously paused have been reinstated and no new contracts have been affected.
IBM maintained its annual sales forecast of at least 5 per cent growth in constant currency. Free cash flow is projected to exceed US$13.5 billion, in line with analysts' estimates. BLOOMBERG
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
9 minutes ago
- Straits Times
Luka Doncic signs 3-year, $165m contract extension with Los Angeles Lakers
Sign up now: Get ST's newsletters delivered to your inbox Since joining the Lakers in February, Doncic has averaged 28.2 points, 8.1 rebounds, 7.5 assists and 1.6 steals over 28 games. LOS ANGELES - The Los Angeles Lakers have signed five-time NBA All-Star guard Luka Doncic to a three-year, US$165 million (S$212 million) contract extension, securing the long-term future of one of basketball's brightest stars, the team announced on Aug 2. 'I just signed my extension with the Lakers,' Doncic wrote in a social media post. 'Excited to keep working to bring championships to LA and make Laker Nation proud. Grateful to the Lakers, my teammates and all the fans who've shown so much love since day one. This is just the beginning.' Lakers president of basketball operations and general manager Rob Pelinka called it a 'monumental moment' for the franchise. 'Luka Doncic's future is with the Los Angeles Lakers,' Pelinka said in a statement. 'Luka is one of the game's most transcendent players, and his on-court dominance and passion is without compare.' Doncic, 26, was acquired by Los Angeles in a blockbuster trade in February that sent Anthony Davis to the Mavericks in a move that stunned the sports world. Top stories Swipe. Select. Stay informed. Singapore $3b money laundering case: MinLaw names 6 law firms taken to task over involvement in property deals Singapore Police reopen access to all areas in Marina Bay after crowd congestion eases at NDP Preview area Singapore Opening of Woodlands Health has eased load on KTPH, sets standard for future hospitals: Ong Ye Kung Asia KTM plans new passenger rail service in Johor Bahru to manage higher footfall expected from RTS Singapore HSA investigating teen allegedly vaping on MRT train Asia 4 workers dead after falling into manhole in Japan Singapore New vehicular bridge connecting Punggol Central and Seletar Link to open on Aug 3 Singapore New S'pore jobs portal launched for North West District residents looking for work near home Since joining the Lakers, he has averaged 28.2 points, 8.1 rebounds, 7.5 assists and 1.6 steals over 28 games to close the regular season, helping lift the Lakers to the third seed in the Western Conference. The Slovenian guard, who was the third overall pick in the 2018 NBA Draft, boasts career averages of 28.6 points, 8.6 rebounds and 8.2 assists across seven NBA seasons with the Dallas Mavericks and Lakers. Doncic, who has been selected five times to the All-NBA first team, led the league in scoring during the 2023-24 campaign with 33.9 points per game and recorded a career-high 73 points in a single contest. He ranks third all-time in regular season scoring average and has notched 82 career triple-doubles, fourth among active players. REUTERS


CNA
4 hours ago
- CNA
Malaysia businesses respond to latest Trump tariff announcement
Businesses in Malaysia remain cautious despite the decision by the US to reduce tariffs on Malaysian imports. But the reduction at least helps the overall cost competitiveness of Malaysian-manufactured goods in the US market. Businesses and manufacturers are also bracing for higher operating costs and potential price hikes. Afifah Ariffin reports.


International Business Times
11 hours ago
- International Business Times
Vietnam Marks Medical Breakthrough With First Robotic Pediatric Brain Procedure
Robotic systems are fast becoming the new standard worldwide. According to Frontiers, the global medical robots market was valued at approximately US$27.7 billion in 2023, and is projected to hit US$127 billion by 2033, growing at a CAGR of 16.5%. Europe and North America remain leaders in adoption. In 2023, Europe alone had over 3,500 surgical robotic systems and performed more than 280,000 robotic surgeries, according to MarketGrowthReports. "Innovation like robot-assisted surgery isn't science fiction, it's the future of the health service," said UK Health Secretary Wes Streeting in The Scottish Sun. That future is no longer limited to the West. It has arrived in Southeast Asia, specifically, Vietnam. At Vinmec Central Park International Hospital (Ho Chi Minh City), surgeons performed the country's first pediatric stereo-electroencephalography (SEEG) using the AutoGuide™ robotic guidance system on a 9-year-old boy with drug-resistant epilepsy. The patient, B.Q.K. from Hanoi, had suffered from epilepsy since 2021. Despite undergoing multiple treatments in Vietnam and abroad, his seizures persisted. For five years, his family sought a solution that could restore their son's quality of life and allow for seizure-free sleep. That solution arrived in 2025. On June 17, 2025, a surgical team led by Dr. Truong Van Tri, with support from Japanese epilepsy expert Assoc. Prof. Dr. Shunsuke Nakae, performed a high-precision resection. The young patient after a life-changing breakthrough Handout Using AutoGuide, Vinmec doctors successfully implanted electrodes deep into the orbitofrontal cortex and inferior frontal gyrus—regions densely packed with neural networks and blood vessels. The robot worked in tandem with advanced imaging tools, including a 3.0 Tesla MRI and multi-channel EEG systems, to visualize the brain and track seizure activity. These technologies allowed the clinical team to identify the epileptogenic zone with high confidence, something that conventional surface EEG, PET, or MRI alone often fail to do in pediatric cases. "For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri. The patient experienced no postoperative neurological deficits. Within a month, he returned to regular play, and his seizure frequency decreased by more than 95%, a life-changing turnaround. New Hope for Drug-Resistant Epilepsy Patients According to the World Health Organization, approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. Surgery is often the most effective option for these patients, but it relies heavily on accurately localizing the epileptogenic zone. This process becomes even more difficult in children, where traditional tools like scalp EEG, MRI, and PET often yield inconclusive results. Robotic SEEG offers a minimally invasive and highly accurate alternative. Vinmec Central Park advances neurology through technology and international integration By combining robotic precision with multidisciplinary expertise, Vinmec Central Park is now among the few hospitals in Asia capable of performing pediatric SEEG with robotic assistance. Recognized as Vietnam's top private hospital system for expatriates and international patients (based on independent surveys), Vinmec is advancing the frontiers of neurology and precision medicine in Southeast Asia. This achievement reflects Vinmec's long-term strategy to develop centers of excellence through cutting-edge technology, personalized treatment, and global collaboration. As Vietnam continues to invest in AI, robotics, and precision healthcare, such milestones offer new possibilities for patients once deemed untreatable.